Pelthos Therapeutics Slides 8.8% as Market Volatility Hits $19.59 Share Price
Pelthos Therapeutics’ stock slumps 8.8% amid broader biotech volatility, dropping below its 200‑day average—investors eye clinical data for a potential rebound.
- PELTHOS THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read